Baxter International (BAX) Stock Price, News & Analysis

Company Overview

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Key Stats

• Today's Range: $34.94 to $36.05
• 50-Day Range: $34.51 to $40.26
• 52-Week Range: $31.01 to $44.01
• Volume: 4.11 million shs
• Average Volume: 4.15 million shs
• Market Capitalization: $17.88 billion
• P/E Ratio: 6.75
• Dividend Yield: 3.31%
• Price Target: $42.00
• Consensus Rating: Hold

Baxter International Stock Analysis - MarketRank™

Baxter International scored higher than 96% of companies evaluated by MarketBeat, and ranked 50th out of 995 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Hold

Consensus Rating

Baxter International has received a consensus rating of Hold. The company's average rating score is 2.09, and is based on 2 buy ratings, 8 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Baxter International has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 8.11%

Earnings Growth

Earnings for Baxter International are expected to grow by 8.11% in the coming year, from $2.96 to $3.20 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Baxter International is 6.75, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 135.36.

Price to Earnings Ratio vs. Sector

The P/E ratio of Baxter International is 6.75, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 140.65.

Price to Earnings Growth Ratio

Baxter International has a PEG Ratio of 1.32. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Baxter International has a P/B Ratio of 2.10. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.59% of the outstanding shares of Baxter International have been sold short.

Short Interest Ratio / Days to Cover

Baxter International has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Baxter International has recently increased by 21.21%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Baxter International pays a meaningful dividend of 3.00%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Baxter International does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Baxter International is 22.31%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Baxter International will have a dividend payout ratio of 36.25% next year. This indicates that Baxter International will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 4.0 / 5
• Environmental Score: -1.95

Percentage of Shares Shorted

2.59% of the outstanding shares of Baxter International have been sold short.

Short Interest Ratio / Days to Cover

Baxter International has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Baxter International has recently increased by 21.21%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: 0.39

News Sentiment

Baxter International has a news sentiment score of 0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 15 news articles for Baxter International this week, compared to 7 articles on an average week.

Search Interest

Only 15 people have searched for BAX on MarketBeat in the last 30 days. This is a decrease of -58% compared to the previous 30 days.

MarketBeat Follows

4 people have added Baxter International to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Baxter International insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.21% of the stock of Baxter International is held by insiders.

Percentage Held by Institutions

90.19% of the stock of Baxter International is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

BAX Stock Analysis - Frequently Asked Questions

How have BAX shares performed this year?

Baxter International's stock was trading at $38.66 on January 1st, 2024. Since then, BAX shares have decreased by 9.3% and is now trading at $35.08.
View the best growth stocks for 2024 here.

How were Baxter International's earnings last quarter?

Baxter International Inc. (NYSE:BAX) posted its quarterly earnings data on Tuesday, August, 6th. The medical instruments supplier reported $0.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.66 by $0.02. The business's revenue for the quarter was up 2.8% on a year-over-year basis.
Read the conference call transcript.

Does Baxter International have any subsidiaries?

Baxter International subsidiaries include Cheetah Medical, ApaTech Limited, Baxter AO, Baxter Belgium SPRL, Baxter (China) Investment Co. Ltd, Baxter Company Ltd, Baxter Corporation (Canada), and more.

Who are Baxter International's major shareholders?

Baxter International's top institutional investors include Trust Co. of Toledo NA OH, Neville Rodie & Shaw Inc., SG Americas Securities LLC and Jacobs & Co. CA. Insiders that own company stock include Jeanne K Mason, Albert P L Stroucken, Jacqueline Kunzler and Brian Stevens.
View institutional ownership trends.

How do I buy shares of Baxter International?

Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Baxter International investors own include Xtrackers California Municipal Bond ETF (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Intel (INTC) and Abbott Laboratories (ABT).

Company Calendar

• Last Earnings: 8/06/2024
• Ex-Dividend for 10/1 Dividend: 8/30/2024
• Dividend Payable: 10/01/2024
• Today: 10/03/2024
• Next Earnings (Estimated): 11/07/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:BAX
• CUSIP: 07181310
• CIK: 10456
• Web: www.baxter.com
• Phone: (224) 948-2000
• Fax: 224-948-1813
• Employees: 60,000
• Year Founded: 1931

Price Target and Rating

• Average Stock Price Target: $42.00
• High Stock Price Target: $54.00
• Low Stock Price Target: $30.00
• Potential Upside/Downside: +16.8%
• Consensus Rating: Hold
• Rating Score (0-4): 2.09
• Research Coverage: 11 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $5.20
• Trailing P/E Ratio: 6.92
• Forward P/E Ratio: 12.15
• P/E Growth: 1.32
• Net Income: $2.66 billion
• Net Margins: 16.51%
• Pretax Margin: -0.50%
• Return on Equity: 18.06%
• Return on Assets: 5.21%

Debt

• Debt-to-Equity Ratio: 1.35
• Current Ratio: 1.40
• Quick Ratio: 0.91

Sales & Book Value

• Annual Sales: $15.00 billion
• Price / Sales: 1.22
• Cash Flow: $4.83 per share
• Price / Cash Flow: 7.44
• Book Value: $16.69 per share
• Price / Book: 2.16

Miscellaneous

• Outstanding Shares: 509,580,000
• Free Float: 508,510,000
• Market Cap: $18.33 billion
• Optionable: Optionable
• Beta: 0.59